Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ian Chau Masatoshi Kudo Hyun Cheol Chung Ronnie T P Poon |
| Publication date | June 18, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |